Biologically active peptides

Details Biologically active peptides Biologically active peptides

2008-07-22

2008-07-22

Gambel, Phillip (Department: 1644)

Chemistry: natural resins or derivatives; peptides or proteins;

Peptides of 3 to 100 amino acid residues

Insulin; related peptides

C530S327000, C514S002600, C514S014800

Reexamination Certificate

active

11455289

ABSTRACT:
Thirty substantially pure and biologically active peptides are disclosed. Nucleic acids that have sequences coding for the biologically active peptides and pharmaceutical formulations produced thereform are also disclosed.

REFERENCES:
patent: 3992364 (1976-11-01), Kuhlmey
patent: 5504190 (1996-04-01), Houghten et al.
patent: 5529908 (1996-06-01), Palva et al.
patent: 5760000 (1998-06-01), Habibi
patent: 5861483 (1999-01-01), Wolpe
patent: 5874405 (1999-02-01), Birnbaum et al.
patent: 5932224 (1999-08-01), Chisari
patent: 5968514 (1999-10-01), Johnson et al.
patent: 6036952 (2000-03-01), Oh
patent: 6207456 (2001-03-01), Baru et al.
patent: 6245427 (2001-06-01), Duzgunes et al.
patent: 6268169 (2001-07-01), Fahnestock
patent: 6391585 (2002-05-01), Jang et al.
patent: 41 22 585 (1993-01-01), None
patent: 197 00 535 (1998-07-01), None
patent: 257406 (1988-03-01), None
patent: 382012 (1990-08-01), None
patent: 0 389 583 (1992-11-01), None
patent: 1142571 (1969-02-01), None
patent: WO 90/01326 (1990-02-01), None
patent: WO 95/35389 (1995-12-01), None
patent: WO 97/35602 (1997-10-01), None
patent: WO 98/12219 (1998-03-01), None
patent: WO98/59071 (1998-12-01), None
patent: WO 99/00418 (1999-01-01), None
patent: WO00/12762 (2000-03-01), None
patent: WO 00/63233 (2000-10-01), None
patent: WO01/29228 (2001-04-01), None
patent: WO 03/006492 (2003-01-01), None
Ivanov et al. Biopolymers. 1997, 43:171-188.
The Merck Manuals Online Medical Library, [online]. Whitehouse Station, NJ: Merck Research Laboratories, 2006-2007. [retrieved on Jun. 9, 2007]. Retrieved from the Internet: < URL:http://www.merck.com/mmpe/print/sec10/ch128/ch128d.html>. Kaposi's Sarcoma, see pp. 1-2.
The Merck Manuals Online Medical Library, [online]. Whitehouse Station, NJ: Merck Research Laboratories, 2006-2007. [retrieved on Jun. 9, 2007]. Retrieved from the Internet: < URL:http://www.merck.com/mmpe/print/sec03/ch027/ch027b.html>. Acute Viral Hepatitis, pp. 1-9.
Bulant et al. (1990) Processing of thyrotropin-releasing hormone prohormone (pro-TRH) generates a biologically active peptide, prepro-TRH-(160-169), which regulates TRH-induced thyrotropin secretion. Proceedings of the National Academy of Sciences of the USA, 87(12):4439-4443.
Chang et al. (1980) Isolation and structure of several peptides from porcine hypothalami. Biochimica et Biophysica Acta, 625:266-273.
Fogaca et al. (1999) Antimicrobial activity of a bovine hemoglobin fragment in the tickBoophilus microplus. The Journal of Biological Chemistry, 274(36):25330-25334.
Furka et al. (2000) String synthesis. A spatially addressable split procedure. J Comb Chem 2:220-223.
James et al. (1992) Linear epitope mapping of an SM B/B polypeptide. Journal of Immunology. 148:2074-2079.
Karelin et al. (1995) Proteolytic degradation of hemoglobin in erythrocytes leads to biologically active peptides. Peptides, 16(4):693-697.
Karelin et al. (1998) Proteolytic degradation of hemoglobin in erythrocytes yields biologically active peptides. Bioorganicheskaia Khimiia, 24(4):271-281. (Russian).
Ladram et al. (1992) Characterization of receptors for thyrotropin-releasing hormone-potentiating peptide on rat anterior pituitary membranes. The Journal of Biological Chemistry, 267(36):25697-25702.
Mikayama et al. (1993) Molecular cloning and functional expression of a cDNA encoding glycosylation-inhibiting factor. Proc. Natl. Acad. Sci. 90:10056-10060.
Ngo et al. (1994) Computational complexity, protein structure prediction, and the levinthal paradox. The Protein Folding Problem and Tertiary Structure Prediction. p. 433 and 492-495.
Owens et al. (1992) Structure-activity relationship of the neurotransmitter alpha-bag cell peptide on aplysia LuQ neurons: implications regarding its inactivation in the extracellular space. J of Neurobiology. 23(6):656-670.
Sambrook et al. (1989) Molecular Cloning A Laboratory Manual, second edition. 17 Expression of Cloned Genes inEscherichia coli. CSH. 17.31-17.44.
Schally et al. (1978) Isolation, structural elucidation and synthesis of a tetradecapeptide with in vitro acth-releasing activity corresponding to residues 33-46 of the α-chain of porcine hemoglobin. Biochemical and Biophysical Research Communications, 82(2):582-588.
Squire et al. (1991) Leucine aminopeptidase-like activity in aplysia hemolymph rapidly degrades biologically active α-bag cell peptide fragments. The Journal of Biological Chemistry. 266(33):22355-22363.
Whisstock et al. (2003) Prediction of protein function from protein sequence and structure. Quarterly Reviews of Biophysics. 36:307-340.
Chem. Abs. No. 138168-48-6 dated Jan. 3, 1992.
International Preliminary Examination Report from PCT/GB02/03203 dated Mar. 4, 2004.
Examination Report from New Zealand Patent Application No. 529879 dated Mar. 15, 2005.
The amino acid masses, downloaded Apr. 5, 2006 from haven.isb-sib.ch/tools/isotopident/htdocs/aa-list.html, one page.
Moisan et all, (1998). Structural Requirements and mechanism of the Pressor Activity of Leu-Val-Val-hemorphin-7, a Fragment of Hemoglobin B-chain n Rats, Peptides. 19(1) p. 119-131: Printed in USA.
Katoh et al, (1996). Mapping Myosin-Binding Sites on Actin Probed by Peptides that Inhibit Actomyosin Interaction. J. Biochem. 120, p. 580-586.
Hastings et al., (1982). cDNA clone analysis of six co-regulated mRNAs encoding skeletal muscle contractile proteins. Proc. Natl. Acad. Sci. USA vol. 79 p. 1553-1557.
Hietter et al., (1989). Isolation and structure of two novel 6-kDa dimeric peptides from the corpora cardiaca of the insectLocusta migratoria. Eur. J. Biochem. 182, p. 77-84.
Mezo et al., (1989). The Influence of the Side-Chain Sequence on the Structure-Activity Correlations of Immunomodulatory Branched Polypeptides. Synthesis and Conformational Analysis of New Model Polypeptides. Biopolymers, vol. 28, p. 1801-1826.
Westermann et al., (1990). Synthetic peptides identify the minimal substrate requirements of tubulin polyglutamylase in side chain elongation. FEBS Letters 459, p. 90-94.
Firtel et al., (1979). Unusual nucleotide sequences at the 5′ end of actin genes in Dictyostelium discoideum. Proc. Natl. Acad. Sci. USA, vol. 76, No. 12, p. 6206-6210.
Genbank AAF04121. http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=protein&val=6118500.
Ding et al., The synthesis, distribution, and anti-hepatic cancer activity of YSL, Bioorganic & Medicinal Chemistry, 2004, 12:4989-4994.
Lai et al., Solid-State Chemical Stability of Proteins and Peptides, Journal of Pharmaceutical Sciences, 1999, 88 (5):489-500.
The amino acid masses, http://haven.isb-sib.ch/tools/isotopident/htdocs/aa-list.html.

Affiliated with

Also associated with

Rating

Biologically active peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Biologically active peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biologically active peptides will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3951874